OCS starts PIONEER-1 trial after first Privosegtor patient treated
OCS says it has treated the first patient in its PIONEER-1 registrational trial of Privosegtor for optic neuritis.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.